• Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
  
• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
  

PubMed=9342843; DOI=10.1046/j.1432-0436.1997.6150321.x
Kathryn Nason-Burchenal, Wolfgang Maerz, Joan Albanell, Janet J. Allopenna, Patrick Martin, Malcolm A.S. Moore, Ethan Dmitrovsky;
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Differentiation 61:321-331(1997)

PubMed=9716606; DOI=10.1182/blood.V92.5.1758
Kathryn Nason-Burchenal, Janet J. Allopenna, Agnes Begue, Dominique Stehelin, Ethan Dmitrovsky, Patrick Martin;
Targeting of PML/RARalpha is lethal to retinoic acid-resistant promyelocytic leukemia cells.
Blood 92:1758-1767(1998)

PubMed=11704857; DOI=10.1038/sj.onc.1204863
Mathilde J.S. Roussel, Michel Lanotte;
Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes.
Oncogene 20:7287-7291(2001)